Design and analysis of cross-over trials B Jones, MG Kenward Chapman and Hall/CRC, 2003 | 2198 | 2003 |
Trials to assess equivalence: the importance of rigorous methods B Jones, P Jarvis, JA Lewis, AF Ebbutt Bmj 313 (7048), 36-39, 1996 | 1168 | 1996 |
Guidelines for controlled trials of drugs in migraine International Headache Society Clinical Trials Subcommittee, ... Cephalalgia 20 (9), 765-786, 2000 | 753 | 2000 |
Statistical inference PH Garthwaite, IT Jolliffe, B Jones OUP Oxford, 2002 | 396 | 2002 |
Bioequivalence and statistics in clinical pharmacology SD Patterson, B Jones Chapman and Hall/CRC, 2017 | 202 | 2017 |
Exchange and interchange procedures to search for optimal designs B Jones, JA Eccleston Journal of the Royal Statistical Society Series B: Statistical Methodology …, 1980 | 97 | 1980 |
The analysis of data from 2× 2 cross‐over trials with baseline measurements MG Kenward, B Jones Statistics in Medicine 6 (8), 911-926, 1987 | 90 | 1987 |
A log‐linear model for binary cross‐over data MG Kenward, B Jones Journal of the Royal Statistical Society: Series C (Applied Statistics) 36 …, 1987 | 73 | 1987 |
Statistical approaches for conducting network meta‐analysis in drug development B Jones, J Roger, PW Lane, A Lawton, C Fletcher, JC Cappelleri, H Tate, ... Pharmaceutical Statistics 10 (6), 523-531, 2011 | 70 | 2011 |
The design of multicentre trials V Fedorov, B Jones Statistical Methods in Medical Research 14 (3), 205-248, 2005 | 70 | 2005 |
Modelling binary data from a three‐period cross‐over trial B Jones, MG Kenward Statistics in Medicine 6 (5), 555-564, 1987 | 70 | 1987 |
Equireplicate balanced block designs with unequal block sizes SC Gupta, B Jones Biometrika 70 (2), 433-440, 1983 | 67 | 1983 |
Modelling and design of cross‐over trials B Jones, AN Donev Statistics in Medicine 15 (13), 1435-1446, 1996 | 59 | 1996 |
A comparison of various estimators of a treatment difference for a multi‐centre clinical trial B Jones, D Teather, J Wang, JA Lewis Statistics in medicine 17 (15‐16), 1767-1777, 1998 | 57 | 1998 |
Alternative approaches to the analysis of binary and categorical repeated measurements MG Kenward, B Jones Journal of Biopharmaceutical Statistics 2 (2), 137-170, 1992 | 56 | 1992 |
Kullback–Leibler divergence for evaluating bioequivalence V Dragalin, V Fedorov, S Patterson, B Jones Statistics in medicine 22 (6), 913-930, 2003 | 53 | 2003 |
The case for cross‐over trials in phase III B Jones, JA Lewis Statistics in Medicine 14 (9), 1025-1038, 1995 | 48 | 1995 |
Efficient repeated measurements designs with equal and unequal period sizes I Iqbal, B Jones Journal of statistical planning and inference 42 (1-2), 79-88, 1994 | 47 | 1994 |
An algorithm for deriving optimal block designs B Jones Technometrics 18 (4), 451-458, 1976 | 46 | 1976 |
Batch‐to‐batch pharmacokinetic variability confounds current bioequivalence regulations: a dry powder inhaler randomized clinical trial E Burmeister Getz, KJ Carroll, B Jones, LZ Benet Clinical Pharmacology & Therapeutics 100 (3), 223-231, 2016 | 45 | 2016 |